The optimal management of patients with diabetes is a multifaceted issue that requires the concomitant control of blood pressure, glycemic, HbA1c, and lipid levels. While accomplishing those goals may further reduce mortality by an additional 40-60%, less than 10% of the population is able to achieve those modest profiles. Populations that tend to struggle with achieving optimal outcomes are those who are “non-engaged”, perhaps due to personal limitations and/or the lack of resources. The latter is especially notable because, unfortunately, access to care, necessary medications, and beneficial lifestyle modifications are all expensive as well. Furthermore, T2DM rarely travels alone, and the pill burden that is associated with concurrent management of multiple comorbid conditions is frequently taxing to patients.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen